In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents
- Autores
- Alomar, María L.; Rasse-Suriani, Federico; Ganuza, Agustina; Cóceres, Verónica; Cabrerizo, Franco M.; Angel, Sergio Oscar
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).
- Materia
-
Ciencias Biológicas
Toxoplasma gondii
β-carbolines
drug
invasion
cell cycle - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/4.0/
- Repositorio
.jpg)
- Institución
- Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
- OAI Identificador
- oai:digital.cic.gba.gob.ar:11746/2209
Ver los metadatos del registro completo
| id |
CICBA_d3689abc43543edcb1c555029fda872d |
|---|---|
| oai_identifier_str |
oai:digital.cic.gba.gob.ar:11746/2209 |
| network_acronym_str |
CICBA |
| repository_id_str |
9441 |
| network_name_str |
CIC Digital (CICBA) |
| spelling |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agentsAlomar, María L.Rasse-Suriani, FedericoGanuza, AgustinaCóceres, VerónicaCabrerizo, Franco M.Angel, Sergio OscarCiencias BiológicasToxoplasma gondiiβ-carbolinesdruginvasioncell cycleBackground: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero).BioMed Central2013info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttps://digital.cic.gba.gob.ar/handle/11746/2209enginfo:eu-repo/semantics/altIdentifier/doi/10.1186/1756-0500-6-193info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/reponame:CIC Digital (CICBA)instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Airesinstacron:CICBA2025-11-06T09:36:25Zoai:digital.cic.gba.gob.ar:11746/2209Institucionalhttp://digital.cic.gba.gob.arOrganismo científico-tecnológicoNo correspondehttp://digital.cic.gba.gob.ar/oai/snrdmarisa.degiusti@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:94412025-11-06 09:36:25.934CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Airesfalse |
| dc.title.none.fl_str_mv |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| title |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| spellingShingle |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents Alomar, María L. Ciencias Biológicas Toxoplasma gondii β-carbolines drug invasion cell cycle |
| title_short |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| title_full |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| title_fullStr |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| title_full_unstemmed |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| title_sort |
In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents |
| dc.creator.none.fl_str_mv |
Alomar, María L. Rasse-Suriani, Federico Ganuza, Agustina Cóceres, Verónica Cabrerizo, Franco M. Angel, Sergio Oscar |
| author |
Alomar, María L. |
| author_facet |
Alomar, María L. Rasse-Suriani, Federico Ganuza, Agustina Cóceres, Verónica Cabrerizo, Franco M. Angel, Sergio Oscar |
| author_role |
author |
| author2 |
Rasse-Suriani, Federico Ganuza, Agustina Cóceres, Verónica Cabrerizo, Franco M. Angel, Sergio Oscar |
| author2_role |
author author author author author |
| dc.subject.none.fl_str_mv |
Ciencias Biológicas Toxoplasma gondii β-carbolines drug invasion cell cycle |
| topic |
Ciencias Biológicas Toxoplasma gondii β-carbolines drug invasion cell cycle |
| dc.description.none.fl_txt_mv |
Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero). |
| description |
Background: Toxoplasmosis is a worldwide infection caused by the protozoan parasite Toxoplasma gondii, which causes chorioretinitis and neurological defects in congenitally infected newborns or immunodeficient patients. The efficacy of the current treatment is limited, primarily by serious host toxicity. In recent years, research has focused on the development of new drugs against T. gondii. β-Carbolines (βCs), such as harmane, norharmane and harmine, are a group of naturally occurring alkaloids that show microbicidal activity. In this work, harmane, norharmane and harmine were tested against T. gondii. Findings: The treatment of extracellular tachyzoites with harmane, norharmane and harmine showed a 2.5 to 3.5- fold decrease in the invasion rates at doses of 40 μM (harmane and harmine) and 2.5 μM (norharmane) compared with the untreated parasites. Furthermore, an effect on the replication rate could also be observed with a decrease of 1 (harmane) and 2 (norharmane and harmine) division rounds at doses of 5 to 12.5 μM. In addition, the treated parasites presented either delayed or no monolayer lysis compared with the untreated parasites. Conclusions: The three βC alkaloids studied (norharmane, harmane and harmine) exhibit anti-T. gondii effects as evidenced by the partial inhibition of parasite invasion and replication. A dose–response effect was observed at a relatively low drug concentration (< 40 μM), at which no cytotoxic effect was observed on the host cell line (Vero). |
| publishDate |
2013 |
| dc.date.none.fl_str_mv |
2013 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://digital.cic.gba.gob.ar/handle/11746/2209 |
| url |
https://digital.cic.gba.gob.ar/handle/11746/2209 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1186/1756-0500-6-193 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
BioMed Central |
| publisher.none.fl_str_mv |
BioMed Central |
| dc.source.none.fl_str_mv |
reponame:CIC Digital (CICBA) instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Aires instacron:CICBA |
| reponame_str |
CIC Digital (CICBA) |
| collection |
CIC Digital (CICBA) |
| instname_str |
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires |
| instacron_str |
CICBA |
| institution |
CICBA |
| repository.name.fl_str_mv |
CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires |
| repository.mail.fl_str_mv |
marisa.degiusti@sedici.unlp.edu.ar |
| _version_ |
1848045406915657728 |
| score |
13.084122 |